1. Composition of IVF expenses: Details from basic to high-end
IVF fees are not charged for a single item, but are composed of multiple links. Different generations of technologies, individual differences and regional economic levels will affect the final expenditure. The following are common fee categories
1. Basic medical expenses
·Preoperative examination: Both husband and wife need to undergo hormone levels, chromosomes, infectious diseases, etc. screening, and the cost is about 3,000 - 8,000 yuan.
·:(/),.Domestic drugs are about 50 - 15,000 yuan, and imported drugs can reach 20,000 - 30,000 yuan.
· Egg retrieval and embryo culture: This includes surgical procedures, laboratory fertilization, and embryo cultivation. The cost is approximately 20,000 to 40,000 yuan.
·Single Sperm Injection (ICSI): An additional 50 - 10,000 yuan will be added for male infertility.
· Intracytoplasmic sperm injection (ICSI): This procedure is available for men with infertility issues. The cost of this treatment is additional $5,000 to $10,000.
· Embryo cryopreservation: The initial storage fee is approximately 5,000 yuan, with subsequent annual fees ranging around 2,000 yuan.
· Genetic Screening (PGT): The core technology of third-generation IVF, used for detecting chromosomal or genetic disorders. The cost increases by 30,000 to 80,000 yuan.
·Multiple transplants: If the first time fails, the embryos will need to be expelled or thawed repeatedly in subsequent cycles, and the cost may double.
· Multiple transfers: If the first attempt fails, subsequent cycles may require repeated ovulation induction or embryo thawing. The cost could potentially double in such cases.
· Complication management: For example, treatment of ovarian hyperstimulation syndrome (OHSS) can result in additional expenses of several thousand yuan.

nFee Range Summary
Firstgeneration (IVF): 30,000 - 50,000 yuan
Secondgeneration (ICSI): 40,000 - 60,000 yuan
Thirdgeneration (PGT): 80,000 - 150,000 yuan

2. Why is the cost so high? Four core reasons

1. Technical threshold and equipment investment
IVF relies on precision instruments (such as embryo incubators and microscopic operating systems) and high-standard laboratories. The construction cost is between millions and tens of millions of yuan, and the cost will inevitably be distributed to patients.
From reproductive doctors, embryologists to psychological counselors, multidisciplinary collaboration is needed.
,,.Dozens of monitoring times are required in a single cycle, and labor costs account for about 30%.
Ovulation promotion drugs (Ruifen) rely on imports and are expensive; although domestic alternatives are 30%-50% cheaper, their effectiveness and stability are uneven.
Ovulation-stimulating drugs like Nafzin depend on imports, and their prices are quite high. While domestic alternatives are 30%-50% cheaper, their effectiveness and stability vary greatly.
Elderly or complex cases may take 2-3 cycles, and the total cost can reach 100,000 - 200,000 yuan.
For elderly patients or those with complex conditions, it may take 2-3 cycles to complete the treatment. The total cost can range from 100,000 to 200,000 yuan.

3. How do ordinary people respond? Practical fee reduction strategy

1. Scientific planning to avoid blind attempts
Earlytreatment is recommended to reduce the number of cycles.
· Accurate assessment: Through AMH testing and hysteroscopy, we can predict the success rate of treatment, thereby avoiding ineffective investments.
·No upgrade if necessary: If there is no genetic history or severe male infertility, there is no need to force third-generation technology.
· Upgrade only when necessary: If there is no family history of genetic diseases or severe male infertility, there is no need to insist on third-generation technologies.
· Using domestic medications as alternatives: Using domestically produced ovulation-stimulating drugs under the guidance of a doctor can save 30% on medication costs.
·Medical insurance reimbursement: Starting from 2023, Guangxi, Beijing and other places will include some test tube items in medical insurance, such as egg retrieval, embryo transfer, etc., with a higher reimbursement rate of 50%.
· Medical insurance reimbursement: Starting from 2023, some IVF procedures in regions such as Guangxi and Beijing will be covered by medical insurance. This includes procedures like egg retrieval and embryo transfer, with a maximum reimbursement rate of 50%.
· Commercial insurance: Some insurance companies have introduced “test-tube baby insurance” programs, which cover the costs associated with multiple failed attempts at conception.
Laos, Thailand and other places have 30%-50% lower costs (about 80,000 - 120,000 yuan) than those in Europe and the United States, and provide legal genetic screening services, suitable for families with limited budgets but with genetic risks.
The cost of third-generation IVF in countries like Laos and Thailand is 30%-50% lower than in Europe and America (approximately 80,000 to 120,000 yuan). Additionally, these regions offer legal genetic screening services, making them suitable for families with limited budgets but who still face genetic risks.

4. Reasonably treating costs: technological inclusion and future prospects

Althoughcurrent costs are still a challenge for ordinary families, the industry is moving in a more accessible direction

·Domestic substitution is accelerating: Companies such as Lizhu Pharmaceutical have already achieved the localization of some drugs and devices, and costs are expected to drop in the future.
· Medical insurance coverage expansion: The government is promoting the inclusion of assisted reproductive technologies within basic medical insurance. It is expected that by 2030, the coverage rate will exceed 60%.
· Public welfare assistance is on the rise: Organizations such as the China Population Welfare Foundation have established special funds to provide subsidies of 50,000 to 100,000 yuan to families with financial difficulties.
The high cost of IVF is the result of the combined action of technology, markets and policies. However, through scientific planning, policy utilization and technological progress, it is entirely possible for ordinary people to realize their childbearing dreams.
,,,,.Instead of stopping because of cost anxiety, it is better to proactively understand information and plan paths to make every investment more efficient. The road to childbirth may be difficult, but hope is always ahead.